PBC https://validator.w3.org/feed/docs/rss2.html Require Your PBM To Take Action on Zytiga Message from Mylan: Pay Attention to Rebates Take Action To Decrease Your Plan’s Crestor Costs Pay Attention to Your Metformin HCL ER Diabetes Costs Additional Information About New Drugs’ Dangers Protect Your Plan Beneficiaries From New Drugs’ Dangers Does Your Health Plan Actually Need the Large Chain Pharmacies In Your Retail Pharmacy Network? (The Short Answer is “No!”) Don’t Be Duped By Manufacturers’ Single Digit Price Increase Pledges Pull Back the Curtain on Manufacturers’ and Switch Operators’ Efforts To Undermine Your Plan’s Cost Savings Efforts Striking Savings Are Possible (But Your Plan Needs To Act To Obtain Them) Want To Decrease Your Rx Coverage Costs? Pay Attention to Horizon Pharma’s 1st Quarter Report Don’t Be Fooled By Eli Lilly’s & Express Scripts’ New Diabetes Program Plan Administrators and Fiduciaries: It’s Time To Take REBATE ACTION – File An Accounting Procedure! Act Now – Block Lyrica CR Preemptively Plan Administrators: Limit Your Restasis Coverage Decreasing Drug Costs – Here’s How We Achieved Them Express Scripts’ Lawsuit Reveals Striking Information About PBM Rebates Your Plan Can ​Decrease Its  Prescription Coverage Costs (But You Need To Take Action To Do So) Create Rational Quantity Limits For Specialty Drugs More Drug Price Increases Cahn to Address IFEBP’s Annual Conference Expert warns: Ohio Medicaid Poised for Big Trouble Recent MS Drug Developments Demonstrate Plans Should Obtain Customized Formularies ASAP ‘For good rather than evil’: Mark Cuban and an employer’s coalition to launch new PBMs to lower drug costs Topic One: PBM Contracts Topic Three: Generic Drugs Topic Two: Specialty Drugs Who We Are Home More Sunshine, Say Some PBM Forecasts. More of the Dark Arts, Say Others. Federal PBM Probe Culminates Decades of M&A AWP: Three little letters that could affect your wallet and health Insurers Slam Critical Drug-Pricing Research But Can’t Vouch For Their Own Inflation Reduction Act Will Mean Big Price Increases On Prescription Drugs Pharmacy Middlemen Sue To Stop Rebate Transparency ‘PBM Busters’ Find Employers Unaware of Price Mark-Ups By Drug Middlemen State’s New Drug Setup Still Riddled With Loopholes New ‘Transparent’ Setup for Medicaid Drug Purchase will be Secret to Public Blog IFEBP’s 29th Annual Health Benefits Conference Topic Five: Coupons Is Ohio’s Revamp On Drug Middlemen Working Even After A Few Years of Drug Price Reforms Across the US, PBMs Are Still Finding Ways Around Them Painful Prescription Time to Lift the Curtain on PBM Wheeling and Dealing Long-Dreaded Amazon Threat to Drug Middlemen Draws Closer Cahn Speaking at the 2021 IFEBP Annual Conference Eliminate All Conflicts of Interest Ohio Medicaid Still Hemorrhaging Money, Expert Testifies Kansas audited its $80 million CVS prescription plan, but it’s still shrouded in mystery